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Occlusion therapy for amblyopia
Electronic monitoring of compliance shows that prescribing longer periods 
of occlusion is not always better 
Some people argue that randomised controlled trials of 
interventions undertaken in microsettings have little rel-
evance for practitioners who need to deliver population-
wide effects.6 This view was partly supported by van 
Sluijs and colleagues’ review,5 which found multicompo-
nent interventions more effective in adolescents. Thus, 
despite the methodological challenges posed, more trials 
of complex interventions are needed.
Importantly, the interventions themselves need to 
be subjected to the same level of scrutiny as the study 
design when assessed for funding and publication, 
and in systematic reviews. Reviewers need to consider 
whether the proposed “dose” of intervention is suffi cient 
to produce an effect and how fi delity with the proposed 
protocol will be (or was) assessed (for example, process 
evaluation). They also need to consider whether ade-
quate formative research was undertaken or proposed, 
to ensure that the intervention is suited to the target 
group and the setting, whether the intervention is based 
on theory, and whether it included efforts to create a 
supportive physical or social environment (or both). All 
of these factors will contribute to the effectiveness of 
interventions.
In the wake of the obesity epidemic, promising 
 multicomponent interventions need to be disseminated, 
while the evidence base continues to be built. High qual-
ity adequately funded evaluation of programmes based 
on best practice principles is also needed. Given the 
complexities involved, partnerships between  academics 
and practitioners are essential.
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Amblyopia affects about 3-5% of the population. 
Occlusion therapy using an eye patch to cover the non-
amblyopic eye for a couple of hours each day has been 
the principal means of treatment. The sensitive period 
in which vision loss can develop and be recovered is 
generally up to 6 years of age.1 In many European 
countries, population based screening and treatment 
by orthoptists has reduced the proportion of people 
with untreated or insuffi ciently treated amblyopia to 
about 1% of the population.2 3
The effectiveness of screening and treatment for 
amblyopia in the United Kingdom has been questioned 
because of insuffi cient evidence from randomised 
controlled trials,4 and an effort is now being made to 
assess its effectiveness and cost. In this week’s BMJ, a 
randomised controlled trial by Stewart and colleagues 
compares the effect of prescribing six or 12 hours of 
occlusion each day in 97 children with amblyopia asso-
ciated with strabismus, anisometropia, or both.5 It is 
the fi rst randomised controlled trial to investigate the 
relation between the duration of occlusion and visual 
acuity, and so it greatly contributes to our understand-
ing of the effectiveness of occlusion therapy.
The potential costs that screening and treatment 
could save in cases where vision in the better eye is 
lost can be calculated: when amblyopia is insuffi ciently 
treated, the duration of bilateral visual impairment 
(visual acuity 6/12 or less—not being able to read) in 
later life is 0.6 years longer than in people without 
amblyopia (average of 1.3 v 0.7 years).6 For example, 
if 1% of the Dutch population had insuffi ciently treated 
amblyopia, 1800 people would be at risk each year for 
bilateral visual impairment. If a visually impaired per-
son costs society €5000 (£3500; $7000), a conservative 
estimate, a minimum of €5.4m could be saved annu-
ally in the Netherlands. Adding to this, the remaining 
patients with insuffi ciently treated amblyopia, who do 
not lose vision in their better eye, have slightly reduced 
quality of life.7
The main cause of insuffi ciently treated amblyopia is 
poor compliance.8 9 Electronic monitoring of compli-
ance with occlusion therapy is now possible with the 
occlusion dose monitor.10 Previous studies using this 
monitor found that compliance averaged 50%,8 even 
though parents knew that compliance was being moni-
tored. Median compliance is 70%, but a considerable 
number of children do not occlude at all. The most 
important non-clinical predictor for poor compliance 
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is poor fl uency in the national language. This can be 
remedied by giving information aimed primarily at the 
child.11
Few guidelines exist when prescribing occlusion 
 therapy. Age, visual acuity, and, to a lesser extent, the 
cause of amblyopia (strabismus, or anisometropia, or 
both) seem to be important determinants when pre-
scribing a certain number of hours. Electronic moni-
toring now allows a precise assessment of the relation 
between the duration of occlusion and the increase in 
visual acuity.
The study by Stewart and colleagues found no sig-
nifi cantly different increase in visual acuity between 
children who were prescribed six hours of occlusion 
each day and those who were prescribed 12 hours. The 
benefi cial effect of wearing glasses was analysed sepa-
rately. Surprisingly, however, the six hour group had 
occluded on average 4 hours a day (standard deviation 
1.7) and the 12 hour group on average 6 hours a day 
(4.1). The study confi rmed that older children need 
more hours of occlusion each day—common knowl-
edge among orthoptists.8 Children younger than 4 
years needed less occlusion (less than three hours a 
day) than children older than 6 (who needed three to 
six hours). Occluding for six hours or more each day 
marginally improved acuity, even in older children. 
A greater number of occlusion hours hastened the 
response but did not improve the fi nal outcome.
Although the study was a randomised controlled 
trial, it was analysed on an “as treated” basis, which 
relates the outcome to the occlusion time actually 
received. However, poor initial visual acuity is the 
most important clinical predictor for poor treatment 
outcome. One reason for this is that children are less 
likely to accept the patch when visual acuity is low.
So what do these results mean for clinical practice? 
As Stewart and colleagues suggest, when evaluat-
ing compliance or a dose-response relation, compli-
ance should be monitored electronically. Relying on 
patients’ reports or diaries is not good enough. Their 
results also show that the perceived hardship of wear-
ing a patch for 12 hours a day, imposed on the child 
and his or her parents, has a negative effect on compli-
ance. Orthoptists and ophthalmologists are becoming 
increasingly aware that when compliance is faltering it 
may be better to prescribe fewer hours of occlusion if it 
means that their instructions are actually carried out. 
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Mental health in disaster settings
New humanitarian guidelines include the needs of people with 
severe mental disorders
Guidelines on mental health and psychosocial sup-
port in emergency settings were launched in Geneva 
last week by the Inter-Agency Standing Committee 
(IASC).1 They will provide guidance on protecting 
and promoting the mental and social wellbeing of all 
people affected by emergencies created by confl ict or 
natural disasters. Among the many topics covered, the 
guidelines also give special attention to people with 
severe mental disorders in the community.
Mental disorders account for four of the 10 leading 
causes of disability worldwide.2 Yet mental health is 
one of the most under-resourced specialties, and no 
country meets its mental health needs even when no 
emergency exists.3 In emergencies, the proportion of 
people with severe mental disorders (such as psycho-
sis or severely disabling moods, anxiety, and stress 
related disorders) is projected to be about 1% higher 
than the estimated baseline of 2-3%.4 In a large emer-
gency this can amount to thousands of people.
People with severe pre-existing mental disorders 
are particularly vulnerable.5 6 A pre-existing disorder 
may be exacerbated by stressful events, by disrupted 
supplies of drugs, and by the lack of social support 
that previously sustained these people. Established 
traditional means of care, such as those provided by 
local spiritual healers, may not function. Patients in 
institutional care may be abandoned by the staff and 
the institution itself may be targeted, taken over, or 
destroyed. People with severe mental disorders may 
not understand the risk of remaining in their surround-
ings, or they may be abandoned by their families and 
communities. If they can be persuaded to escape, they 
may be chained, stoned, and exposed to life threaten-
ing situations in refugee camps. They are also with-
out adequate care and protection because of a lack 
of drugs and trained staff. Stigma may cause families 
to hide a family member who is mentally ill, so the 
person is unable to speak for themself.
Community interventions for people with severe 
mental disorders in emergencies include assessing 
existing services and identifying those in need; build-
ing a relationship with healers and facilitating the 
use of supportive traditional healing methods where 
appropriate; ensuring sustainable supplies of psycho-
tropic drugs; initiating rapid training and ongoing 
supervision for emergency primary healthcare staff; 
and establishing an accessible advertised service while 
avoiding the creation of parallel mental health services 
focused on specifi c diagnoses (such as post-traumatic 
stress disorder) or on narrow groups (such as wid-
ows). The service should provide basic biological and 
psychosocial interventions to relieve symptoms and 
restore function; educate and support existing carers; 
work with local community structures and groups to 
enable protection of people who are severely disabled 
by mental disorder; plan for the return home of any 
